Across TCGA pan-cancer cohorts, OR14J1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OR14J1 data layer compared with 10 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR14J1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR14J1 expression acts as an unfavorable survival marker.

STAD, SKCM, and GBM are the cancer types where OR14J1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	IV	0.001	0.544	<.001	12	view →
SKCM	OS	Median	IV	0.179	0.755	<.001	6	view →
GBM	DFS	Median	All	0.048	0.242	.006	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: OR14J1 tumor-vs-normal RNA expression · all OR14J1 data types